title: Treating osteoporosis: do bisphosphonates really increase the risk of osteonecrosis of the jaw?
authors.forename: E
authors.initials: E
authors.lastname: Thompson
authors.forename: C
authors.initials: C
authors.lastname: Sheehy
authors.forename: M
authors.initials: M
authors.lastname: Barry
authors.forename: J
authors.initials: J
authors.lastname: Carey
mesh_terms: D050071:Bone Density Conservation Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004164:Diphosphonates / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007568:Jaw / Q000187:drug effects* / Q000473:pathology; D010020:Osteonecrosis / Q000139:chemically induced*; D010024:Osteoporosis / Q000188:drug therapy*; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates